BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kesika P, Suganthy N, Sivamaruthi BS, Chaiyasut C. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease. Life Sci 2021;264:118627. [PMID: 33169684 DOI: 10.1016/j.lfs.2020.118627] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin SW, Tsai YS, Chen YL, Wang MF, Chen CC, Lin WH, Fang TJ. Lactobacillus plantarum GKM3 Promotes Longevity, Memory Retention, and Reduces Brain Oxidation Stress in SAMP8 Mice. Nutrients 2021;13:2860. [PMID: 34445020 DOI: 10.3390/nu13082860] [Reference Citation Analysis]
2 Angiolillo A, Gandaglia A, Arcaro A, Carpi A, Gentile F, Naso F, Di Costanzo A. Altered Blood Levels of Anti-Gal Antibodies in Alzheimer's Disease: A New Clue to Pathogenesis? Life (Basel) 2021;11:538. [PMID: 34207559 DOI: 10.3390/life11060538] [Reference Citation Analysis]
3 Banerjee A, Pradhan LK, Sahoo PK, Jena KK, Chauhan NR, Chauhan S, Das SK. Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics. Arch Microbiol 2021;203:2895-910. [PMID: 33763767 DOI: 10.1007/s00203-021-02276-9] [Reference Citation Analysis]
4 Shabbir U, Arshad MS, Sameen A, Oh DH. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies. Nutrients 2021;13:690. [PMID: 33669988 DOI: 10.3390/nu13020690] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
5 Miziak B, Błaszczyk B, Czuczwar SJ. Some Candidate Drugs for Pharmacotherapy of Alzheimer's Disease. Pharmaceuticals (Basel) 2021;14:458. [PMID: 34068096 DOI: 10.3390/ph14050458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Onyango IG, Jauregui GV, Čarná M, Bennett JP Jr, Stokin GB. Neuroinflammation in Alzheimer's Disease. Biomedicines 2021;9:524. [PMID: 34067173 DOI: 10.3390/biomedicines9050524] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Giovannini MG, Lana D, Traini C, Vannucchi MG. The Microbiota-Gut-Brain Axis and Alzheimer Disease. From Dysbiosis to Neurodegeneration: Focus on the Central Nervous System Glial Cells. J Clin Med 2021;10:2358. [PMID: 34072107 DOI: 10.3390/jcm10112358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 De la Fuente M. The Role of the Microbiota-Gut-Brain Axis in the Health and Illness Condition: A Focus on Alzheimer's Disease. J Alzheimers Dis 2021;81:1345-60. [PMID: 33935086 DOI: 10.3233/JAD-201587] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Fulop T, Tripathi S, Rodrigues S, Desroches M, Bunt T, Eiser A, Bernier F, Beauregard PB, Barron AE, Khalil A, Plotka A, Hirokawa K, Larbi A, Bocti C, Laurent B, Frost EH, Witkowski JM. Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer's Disease. Neuropsychiatr Dis Treat 2021;17:1311-39. [PMID: 33976546 DOI: 10.2147/NDT.S264910] [Cited by in F6Publishing: 1] [Reference Citation Analysis]